Table 1. Frequency of pathologic findings of cutaneous silent period (CSP) in subjects with diabetes mellitus. Numerical and percentage incidence of physiological and pathological findings of cutaneous silent period in the control and diabetic subjects were presented.
| GROUPS | CSP | |||
|---|---|---|---|---|
| Physiological | Pathological | |||
| N | % | N | % | |
| Control | 52 | 86.7 | 8 | 13.3 |
| Group 1 | 13 | 43.3 | 17 | 56.7 |
| Group 2 | 13 | 43.3 | 17 | 56.7 |
| Group 3 | 26 | 86.7 | 4 | 13,3 |
| Total | 104 | 69.3 | 46 | 30.7 |